CA 19-9 is a tumor marker used in the diagnosis, assessment of patient response to treatment, and monitoring of patients with pancreatic or hepatobiliary cancer. In the diagnosis of pancreatic cancer, the presence of symptoms of pancreatic or biliary obstruction and elevated CA 19-9 will help the physician conclude the risk of pancreatic cancer rather than a benign pancreatic tumor.

Targeted therapy is cancer therapy by using drugs to limit the growth and spread of cancer, usually applied on patients with advanced cancer, progression and distant metastases that local treatments such as surgery and radiotherapy cannot perform.

CA 19-9 is a tumor marker used in the diagnosis, treatment evaluation, and monitoring of patients with cancer. Quantifying CA 19-9 (carbohydrate antigen 19-9) blood is a special test, supporting the diagnosis of cancer, especially pancreatic cancer.

PSA screening through a general physical examination helps to detect prostate cancer early for appropriate and timely treatment. At Vinmec, the PSA test is quite simple, does not require high technology or modern machines to help men understand their own health status and improve their quality of life.

Testicular cancer is a rare disease, accounting for only about 1% of cancers in men and about 5% of cancers of the genitourinary tract. There are many questions surrounding this disease, but the most interested is still whether testicular cancer can be treated or if testicular cancer can have children.

Nasopharyngeal cancer is a malignant disease, often detected at a late stage because the disease progresses silently, symptoms of the disease are easily confused with other diseases. Detecting early signs of throat cancer makes treatment more convenient.

In some cases, old cells do not die, new cells are still born. The new cells function as the original cells (called differentiation), when a benign tumor occurs and is the result of a genetic mutation in the benign tumor. Benign tumors usually cannot turn malignant, except in cases such as colon polyps.

Researchers at Stanford University School of Medicine have discovered a signal that cancers rely on to evade detection and destruction by the immune system. The scientists said that after blocking this signal in mice transplanted with cancer, the immune cells would begin to attack the cancer cells.